Hirschsprung's Disease (Congenital Aganglionic Megacolon)

Hirschsprungs Disease — scientific infographic poster
  1. Overview and Epidemiology
  2. Genetics and Molecular Pathogenesis
  3. Anatomy of Aganglionosis
  4. Pathophysiology and Clinical Presentation
  5. Diagnosis
  6. Surgical Treatment
  7. Postoperative Outcomes and Complications
  8. HAEC Recognition and Management
  9. Key Research Papers
  10. Connections

Overview and Epidemiology

Hirschsprung's disease (HD), also called congenital aganglionic megacolon, is a congenital defect characterized by the complete absence of ganglion cells (aganglionosis) in the distal bowel. It results from failure of neural crest cells to migrate fully into the hindgut during embryonic development — a process that normally completes between weeks 5 and 12 of gestation. Without ganglion cells, the affected segment of bowel cannot relax or coordinate peristalsis, creating a functional obstruction that causes the normally-innervated proximal bowel to balloon outward: the megacolon.

HD occurs in approximately 1 in 5,000 live births worldwide and is one of the most common causes of neonatal intestinal obstruction. The condition affects males far more often than females in its most common (short-segment) form, with a male-to-female ratio of approximately 4:1. This ratio narrows toward 1:1 in long-segment disease, which is more uniformly distributed across sexes and carries a higher genetic burden.

Most cases are sporadic, but familial clustering is well recognized. Important disease associations include:

Back to Table of Contents

Genetics and Molecular Pathogenesis

HD is a complex genetic disorder in which multiple genes, each with incomplete penetrance, contribute to disease risk. Understanding the genetics is increasingly important as genetic counseling, cancer surveillance, and family planning decisions depend on identifying the causative variant.

RET proto-oncogene (chromosome 10q11.21) is the major susceptibility gene. RET encodes a receptor tyrosine kinase expressed on enteric neural crest cells (NCC). Its signaling is driven by the GDNF (glial cell line-derived neurotrophic factor) / GFRα1 ligand complex. RET activation promotes NCC survival, proliferation, and caudal migration through the developing gut. Loss-of-function mutations in RET — numbering in the hundreds — impair this process and are found in:

The penetrance of RET mutations is incomplete and sex-influenced — males with a pathogenic RET variant have a much higher lifetime risk of HD than females, explaining the strong male predominance in short-segment disease.

Other HD-associated genes and their pathways:

Inheritance patterns vary by segment length and gene involved. Short-segment HD behaves as a low-penetrance dominant trait with strong sex bias; long-segment HD often has higher heritability and may follow more Mendelian patterns when a single high-penetrance gene is involved. In familial cases or cases with associated anomalies, genetic testing panels for HD include at least RET, EDNRB, EDN3, and SOX10.

Back to Table of Contents

Anatomy of Aganglionosis

Understanding where the aganglionic segment begins and how far it extends is fundamental to both diagnosis and surgical planning. There is one anatomical invariant: the aganglionic segment always begins at the internal anal sphincter (IAS) and extends proximally to a variable length. There is no form of HD in which the distal rectum is spared. This is why a normal rectal biopsy at the appropriate level essentially excludes HD.

The normally-innervated bowel contains two ganglionated plexuses:

In HD, both plexuses are absent from the aganglionic segment. This total absence of inhibitory neuronal input means the IAS and the aganglionic bowel remain in a state of tonic contraction, incapable of the coordinated relaxation that normally allows stool to pass.

The transition zone (TZ) — the region between the aganglionic distal bowel and the normally-ganglionated proximal bowel — shows irregular and hypoganglionic (sparse, immature) ganglion cells. Pathologically, the TZ is characterized by hypertrophied, acetylcholinesterase-positive nerve trunks in the submucosa. The TZ is diagnostically important and surgically critical: pull-through procedures place the anastomosis well above the TZ in fully-ganglionated bowel.

Classification by segment length:

Back to Table of Contents

Pathophysiology and Clinical Presentation

The core pathophysiological defect is straightforward: without ganglion cells, the distal bowel cannot relax on command. Stool that reaches the aganglionic segment encounters a tonically contracted segment that acts as a mechanical valve. Proximal bowel distends as stool accumulates above the obstruction — hence megacolon. The rectoanal inhibitory reflex (RAIR) — the normal reflex relaxation of the IAS when the rectum is distended — is absent in HD. This is the physiological basis for anorectal manometry as a diagnostic test.

Neonatal presentation (the majority of HD is diagnosed in the newborn period):

Presentation in older children (milder cases missed in the neonatal period, or ultrashort-segment HD):

Late diagnosis is not rare: In a 2024 series from an Italian centre, 45 of 346 patients (16.4%) were diagnosed after 12 months of age, at a median age of 41 months (range 17 months to 58 years), mostly because their symptoms were mild. 58% of them had passed meconium normally as newborns, significantly more than in children diagnosed earlier. Their complications and later bowel function did not differ significantly from those of children diagnosed on time.

Hirschsprung-Associated Enterocolitis (HAEC) is the most feared acute complication of HD, responsible for the majority of HD-related deaths. HAEC occurs in 15–50% of patients with HD, most commonly in the first months of life before diagnosis (pre-operative HAEC) but also after a technically successful pull-through procedure (post-operative HAEC). Pathogenesis involves bacterial overgrowth in the massively distended proximal bowel, disruption of the mucus barrier, bacterial translocation, and an overwhelming inflammatory cascade. Clinical presentation: fever + explosive foul-smelling diarrhea + severe abdominal distension. The "squirt sign" on rectal exam — explosive discharge when a rectal tube is inserted — is pathognomonic. Without prompt treatment, HAEC progresses to septic shock and colonic perforation. HAEC is a surgical emergency requiring immediate hospitalization, intravenous (IV) antibiotics, and rectal irrigations.

Back to Table of Contents

Diagnosis

The diagnosis of HD rests on three complementary modalities. No single test is 100% sensitive and specific; the clinical picture integrates all available data. In a newborn with failure to pass meconium and abdominal distension, the diagnostic workup is treated as urgent.

Rectal suction biopsy — the gold standard: A suction biopsy device is used to take 3 small mucosal and submucosal specimens at 2, 3, and 4 cm above the dentate line (sampling below 2 cm is unreliable because there is a normal physiologic hypoganglionic zone immediately above the dentate line in all infants). The pathologist evaluates:

Rectal suction biopsy can be performed at the bedside without general anesthesia in neonates and young infants. A full-thickness biopsy under general anesthesia is reserved for cases where suction biopsy is technically inadequate or histologically inconclusive. Calretinin immunostaining is increasingly used as an adjunct — calretinin-positive ganglion cells and nerve fibers are present in normal bowel but absent in aganglionic bowel.

Contrast enema: A water-soluble contrast enema (barium avoided in acutely ill neonates due to perforation risk) is performed without prior rectal preparation (which would wash out the transition zone). The lateral view is the most informative. Classic findings:

Anorectal manometry: Measures the RAIR by inflating a small rectal balloon and recording internal anal sphincter pressure. In normal individuals (even preterm infants beyond ~26 weeks), rectal distension causes reflex relaxation of the IAS. In HD, the RAIR is absent — the IAS fails to relax, or may paradoxically contract. In a prospective study of 111 infants, anorectal manometry had a sensitivity of 83% and a specificity of 93% for HD (see the comparison below); it is particularly useful for evaluating older children with constipation and for post-operative surveillance. It requires technical expertise and is less reliable in very young neonates.

How the three tests compare: In a 2005 study from Amsterdam, 111 infants suspected of HD each had all three tests, and 28 turned out to have HD. Rectal suction biopsy picked up 93% of the children who had HD (sensitivity) and gave no false alarms in those who did not (specificity 100%); the contrast enema scored 76% and 97%, and anorectal manometry 83% and 93%. Results were inconclusive in 2 infants with biopsy, 8 with the enema and 15 with manometry (because the infants were agitated). The differences in accuracy between the tests were not statistically significant, but biopsy was the most accurate test and had the fewest inconclusive results, which is why it serves as the reference test.

Key clinical rule: In clinical practice, constipation that began at or near birth — without an identifiable trigger and without a period of normal stooling — is treated as possible HD until proven otherwise. Functional constipation in a true newborn (the first month of life) is a diagnosis of exclusion.

Back to Table of Contents

Surgical Treatment

The definitive treatment of HD is surgical removal of the aganglionic segment with a pull-through procedure — mobilizing normally-ganglionated proximal bowel and bringing it down to the anal verge to create a new, functional anastomosis. The goal is to restore propulsive peristalsis to the rectal outlet while preserving the voluntary external anal sphincter mechanism responsible for continence.

Historical procedures — understanding these helps explain why multiple modern approaches exist and what each prioritizes:

Modern laparoscopic and transanal approaches:

Timing and staging:

Pre-operative rectal irrigations: For infants awaiting pull-through, saline irrigations via a rectal catheter are performed twice daily to decompress the obstructed bowel and reduce the risk of HAEC. Parents are taught the technique for home use; this intervention significantly reduces pre-operative morbidity.

Back to Table of Contents

Postoperative Outcomes and Complications

The long-term prognosis for HD treated at experienced pediatric surgical centers is generally excellent. The majority of children with short-segment HD achieve socially acceptable fecal continence and lead normal lives. However, a meaningful minority experience ongoing bowel dysfunction that requires continued management, and improvement often continues well into adolescence.

Functional outcomes:

Common postoperative complications:

Quality of life: Long-term studies consistently show that the majority of HD patients report good quality of life (QoL). QoL scores continue to improve through adolescence. Psychosocial support — addressing body image, school performance, and peer relationships in children with soiling — is an integral part of long-term HD management. Adolescents who had HD as infants benefit from transition programs that prepare them to manage their own bowel health as adults.

Back to Table of Contents

HAEC Recognition and Management

Hirschsprung-Associated Enterocolitis (HAEC) is the most dangerous complication of HD and the leading cause of HD-related death. Its warning signs (below) are signs hospitals treat as an emergency, in children with diagnosed or suspected HD alike. In a newborn with a swollen belly and fever, HAEC is one of the conditions clinicians weigh before settling on ordinary infectious gastroenteritis.

Pathogenesis: The obstructed, distended proximal bowel provides a reservoir for bacterial overgrowth. The mucus barrier — which normally prevents bacterial attachment to the colonic epithelium — is disrupted in HD patients due to altered mucin composition and goblet cell function. Bacterial translocation triggers a cascade of epithelial injury, cytokine release, and systemic inflammation. The organisms most commonly implicated include Clostridium difficile, Cryptosporidium, and aerobic gram-negative bacteria, though HAEC is often polymicrobial. The exact initiating event varies; HAEC can recur even after resolution of the primary obstruction via pull-through.

Clinical recognition — the HAEC triad:

Additional features: lethargy, poor feeding, vomiting, signs of dehydration, and in severe cases, peritoneal signs suggesting impending perforation. HAEC can progress to septic shock within hours.

Grading: The Pastor HAEC score (based on history, examination, and radiographic findings) stratifies severity and guides urgency of intervention. Radiographs of the abdomen may show dilated loops of bowel, air-fluid levels, pneumatosis intestinalis (gas within the bowel wall — a sign of mucosal ischemia and impending perforation), or free air indicating perforation.

In 2017 the American Pediatric Surgical Association's Hirschsprung Disease Interest Group published guidelines for diagnosing HAEC and grading how severe it is from the child's history, examination and X-ray findings, and for treating it (where the child is cared for, diet, antibiotics, rectal irrigations and surgery). The guidelines describe HAEC as the leading cause of serious illness and death in children with Hirschsprung disease and note that clear, standard definitions of HAEC and its treatment had been lacking; written by expert consensus, they are presented as a first step toward standard diagnosis and care.

Acute management:

Prevention and long-term management of recurrent HAEC: Families of children with HD, before and after surgery, are commonly taught rectal irrigation for home use when HAEC risk is raised. Children at high risk of repeat HAEC after surgery (those with prior episodes, total colonic HD, or Down syndrome) are often given regular preventive irrigations; a 2018 meta-analysis found that routine rectal irrigations after surgery lowered HAEC (risk ratio 0.2; 2 case-control studies, 172 patients). Preventive probiotics did not: in a randomized, double-blind, placebo-controlled trial of 62 infants, probiotics given for 3 months after the pull-through did not reduce HAEC, and the same meta-analysis (3 randomized trials, 160 patients) found no reduction (risk ratio 0.6, not statistically significant). Close follow-up and a low threshold for intravenous antibiotics at the first sign of a repeat episode are standard care.

Back to Table of Contents

Key Research Papers

  1. Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45(1):1-14. — Comprehensive review of the molecular genetics of HD covering RET, EDNRB, EDN3, SOX10, and other loci; discusses penetrance, phenotype-genotype correlations, and genetic counseling implications. — PubMed PMID: 17965226
  2. Dasgupta R, Langer JC. Hirschsprung disease. Curr Probl Surg. 2004;41(12):942-88. — Detailed surgical review covering the historical evolution of pull-through procedures (Swenson, Duhamel, Soave) through to modern laparoscopic and transanal approaches, with outcome data for each technique. — PubMed PMID: 15614238
  3. De la Torre-Mondragón L, Ortega-Salgado JA. Transanal endorectal pull-through for Hirschsprung's disease. J Pediatr Surg. 1998;33(8):1283-6. — Seminal description of the modern single-stage transanal endorectal pull-through technique that has become standard of care for short-segment HD. — PubMed PMID: 9722005
  4. De Lorijn F, Reitsma JB, Voskuijl WP, Aronson DC, Ten Kate FJ, Smets AM, Taminiau JA, Benninga MA. Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests. J Pediatr. 2005;146(6):787-92. — Prospective head-to-head comparison of rectal suction biopsy, anorectal manometry, and contrast enema in 111 infants (28 with HD); biopsy had the highest sensitivity (93%) and specificity (100%) and the fewest inconclusive results, though the differences from the other two tests were not statistically significant. — PubMed PMID: 15973319
  5. Gosain A. Established and emerging concepts in Hirschsprung's-associated enterocolitis. Pediatr Surg Int. 2016;32(4):313-20. — Reviews the pathogenesis of HAEC including disrupted mucosal barrier function, altered microbiome, and inflammatory mediators; discusses risk factors and preventive strategies. — PubMed PMID: 26783087
  6. Swenson O. My early experience with Hirschsprung's disease. J Pediatr Surg. 1989;24(8):839-44. — Orvar Swenson's personal account of developing the first curative pull-through procedure in 1948 and the clinical observations that led to understanding HD as a ganglionic disorder. — PubMed PMID: 2671336
  7. Ieiri S, Nakatsuji T, Akiyoshi J, Higashi M, Hashizume M, Suita S, Taguchi T. Long-term outcomes and the quality of life of Hirschsprung disease in adolescents who have reached 18 years or older--a 47-year single-institute experience. J Pediatr Surg. 2010;45(12):2398-402. — Long-term follow-up study of HD patients into adulthood; documents fecal continence rates, QoL scores, and social outcomes; shows ongoing improvement through adolescence. — PubMed PMID: 21129554
  8. Frykman PK, Short SS. Hirschsprung-associated enterocolitis: prevention and therapy. Semin Pediatr Surg. 2012;21(4):328-35. — Practical clinical review of HAEC prevention, recognition, grading, and management including the role of rectal irrigations, antibiotics, and surgical intervention thresholds. — PubMed PMID: 22985838
  9. Engum SA, Grosfeld JL. Long-term results of treatment of Hirschsprung's disease. Semin Pediatr Surg. 2004;13(4):273-85. — Large institutional series reporting long-term functional outcomes across multiple pull-through techniques; documents rates of constipation, soiling, HAEC recurrence, and need for redo procedures. — PubMed PMID: 15660321
  10. Rescorla FJ, Morrison AM, Engles D, West KW, Grosfeld JL. Hirschsprung's disease. Evaluation of mortality and long-term function in 260 cases. Arch Surg. 1992;127(8):934-41. — Classic long-term outcome series from Indiana University covering 260 patients; established benchmark mortality and functional outcome data that guided surgical decision-making for decades. — PubMed PMID: 1642536
  11. Friedmacher F, Puri P. Hirschsprung's disease associated with Down syndrome: a meta-analysis of incidence, functional outcomes and mortality. Pediatr Surg Int. 2013;29(9):937-46. — 61 studies: Down syndrome in 7.32% of 16,497 people with HD and HD in 2.62% of 29,418 people with Down syndrome; more enterocolitis, soiling and deaths when both are present. — PubMed PMID: 23943251
  12. Pini Prato A, Erculiani M, Novi ML, Caraccia M, Grandi A, Casella S, Giacometti L, Montobbio G, Mottadelli G. Delayed diagnosis in Hirschsprung disease. Pediatr Surg Int. 2024;40(1):65. — 45 of 346 patients (16.4%) diagnosed after 12 months of age, 58% of them with normal meconium passage. — PubMed PMID: 38436753
  13. Lewis NA, Levitt MA, Zallen GS, Zafar MS, Iacono KL, Rossman JE, Caty MG, Glick PL. Diagnosing Hirschsprung's disease: increasing the odds of a positive rectal biopsy result. J Pediatr Surg. 2003;38(3):412-6. — In 50 children with HD, delayed meconium, vomiting and abdominal distension occurred together in 18%; one or more was present in 98%. — PubMed PMID: 12632358
  14. Gosain A, Frykman PK, Cowles RA, Horton J, Levitt M, Rothstein DH, Langer JC, Goldstein AM; American Pediatric Surgical Association Hirschsprung Disease Interest Group. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517-521. — Expert-consensus guideline for diagnosing, grading and treating HAEC. — PubMed PMID: 28154902
  15. Zhang X, Sun D, Xu Q, Liu H, Li Y, Wang D, Wang J, Zhang Q, Hou P, Mu W, Jia C, Li A. Risk factors for Hirschsprung disease-associated enterocolitis: a systematic review and meta-analysis. Int J Surg. 2023;109(8):2509-2524. — 53 studies, 10,012 children with HD and 2,310 HAEC cases; risk factors and protective factors for HAEC after surgery. — PubMed PMID: 37288551
  16. Soh HJ, Nataraja RM, Pacilli M. Prevention and management of recurrent postoperative Hirschsprung's disease obstructive symptoms and enterocolitis: Systematic review and meta-analysis. J Pediatr Surg. 2018;53(12):2423-2429. — 29 studies: routine postoperative rectal irrigations reduced HAEC; probiotic prophylaxis and routine dilatations did not help; results of myectomy and botulinum toxin for blockage symptoms. — PubMed PMID: 30236605
  17. El-Sawaf M, Siddiqui S, Mahmoud M, Drongowski R, Teitelbaum DH. Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg. 2013;48(1):111-7. — 62 infants; HAEC was not reduced with prophylactic probiotics. — PubMed PMID: 23331802
  18. Adam MP, Conta J, Bean LJH. Classic Mowat-Wilson Syndrome. In: GeneReviews. Seattle (WA): University of Washington, Seattle; 1993-2026 (first posted 2007). — Distinctive facial features, heart defects, Hirschsprung disease and/or chronic constipation, and mostly moderate-to-severe intellectual disability; caused by ZEB2 variants. — PubMed PMID: 20301585
  19. PubMed: Hirschsprung disease RET mutation genetics — Search for current literature on RET proto-oncogene mutations and their role in HD pathogenesis, penetrance, and genetic counseling.
  20. PubMed: Hirschsprung disease Down syndrome epidemiology — Search for studies on the co-occurrence of HD and trisomy 21, including incidence data and management considerations in this high-risk population.

Back to Table of Contents

Connections

Back to Table of Contents